S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
Published on June 9, 2022
As filed with the U.S. Securities and Exchange Commission on June 9, 2022.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
CADRE HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 3842 | 38-3873146 | ||
(State or other jurisdiction of incorporation or organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification Number) |
13386 International Pkwy
Jacksonville, FL 32218
(904) 741-5400
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Warren B. Kanders
13386 International Pkwy
Jacksonville, FL 32218
(904) 741-5400
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies of Communications to:
Robert L. Lawrence, Esq. Kane Kessler P.C. |
Robert W. Downes Ekaterina Roze |
|
600 Third Avenue, 35th Floor New York, New York 10016 (212) 519- 5103 |
Sullivan & Cromwell LLP 125 Broad Street New York, NY 10004 |
|
(212) 558-4000 |
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ¨
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. x 333-265465
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer ¨ | Accelerated filer ¨ | Non-accelerated filer x | Smaller reporting company x |
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
The Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) under the Securities Act.
EXPLANATORY NOTE AND INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
This Registration Statement (the “Registration Statement”) is being filed with the Securities and Exchange Commission (the “Commission”) with respect to the registration of additional shares of common stock, par value $0.0001 per share (the “Common Stock”), of Cadre Holdings, Inc. (the “Registrant”), pursuant to Rule 462(b) under the Securities Act of 1933, as amended. This Registration Statement incorporates by reference the contents of, including all amendments and exhibits thereto, the Registration Statement on Form S-1, as amended (File No. 333-265465) (the “Prior Registration Statement”), which the Commission declared effective on June 9, 2022, and is being filed solely for the purpose of increasing the number of shares of Common Stock to be offered in the public offering by 575,000 shares of Common Stock, including 75,000 shares of Common Stock that may be sold pursuant to the underwriters’ option to purchase additional shares of Common Stock from the Registrant. The additional shares of Common Stock that are being registered for sale are in an amount and at a price that together represent no more than 20% of the maximum aggregate offering price set forth in the Calculation of Registration Fee table contained in the Prior Registration Statement.
The required opinion and consents are listed on the Exhibit Index attached hereto and filed herewith.
EXHIBIT INDEX
Exhibit Number |
Description of Exhibit | |
5.1 | Opinion of Kane Kessler, P.C. | |
23.1 | Consent of KPMG LLP. | |
23.2 | Consent of Kane Kessler, P.C. (included in Exhibit 5.1). | |
107 | Filing Fee Table |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Registration Statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Jacksonville, Florida, on June 9, 2022.
CADRE HOLDINGS, INC. | ||
By: | /s/ Warren B. Kanders | |
Name: Warren B. Kanders | ||
Title: Chief Executive Officer |
Pursuant to the requirements of the Securities Act, this Registration Statement on Form S-1 has been signed by the following persons in the capacities and on the dates indicated.
Signature | Title | Date | ||
/s/ Warren B. Kanders | Chief Executive Officer (Principal Executive Officer) and Chairman | June 9, 2022 | ||
Warren B. Kanders | ||||
* | President | June 9, 2022 | ||
Brad Williams | ||||
* | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | June 9, 2022 | ||
Blaine Browers | ||||
* | Director | June 9, 2022 | ||
Hamish Norton | ||||
* | Director | June 9, 2022 | ||
Nicholas Sokolow | ||||
* | Director | June 9, 2022 | ||
William Quigley | ||||
* | Director | June 9, 2022 | ||
Deborah A. DeCotis |
*By: | /s/ Warren B. Kanders | ||
Warren B. Kanders | |||
Attorney-in-Fact |